home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

BCL11A: a pathologic target gene in lymphoid malignancies

  December, 3 2001 9:32
your information resource in human molecular genetics
Amplifications of a region of chromosome 2p13 have been observed in various B-cell malignancies. After having ruled out several candidate genes, British, German and US researchers were able to identify the BCL11A gene and its 3 major RNA isoforms as the pathologic target for the amplification (Blood. 2001 Dec 1; 98(12):3413-3420). The researchers also reported that a previously identified translocation may contribute to deregulation of the BCL11A locus.

Contact :
P. W. Tucker
University of Texas at Austin, ESB 534, 100W 24th St,
Austin, TX 78705
E-mail: philtucker@mail.utexas.edu
Martin J. S. Dyer
Department of Haematology, University of Leicester
PO Box 65, Leicester, LE2 7LX, UK
E-mail: mjsd1@le.ac.uk.

Message posted by: Ulrike Sattler

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.